Lupin

Lupin Sets Record with Maximum Diabetes Patients Onboarded in Real-World Evidence Study

Mumbai (Maharashtra) [India], April 22: In a groundbreaking achievement, Lupin Limited has set a new benchmark in Real-World Evidence (RWE) research by successfully onboarding 67,802 diabetes patients across 1,336 clinics for one of India’s largest single RWE studies conducted for vildagliptin and its combinations. The study, which was officially confirmed on March 15, 2025, aimed […]

Continue Reading

Lupin Limited Leads Nationwide Blood Pressure Screening and Awareness Drive in Collaboration with ISH and WHL

Mumbai (Maharashtra) [India], June 29:  Lupin Limited, in association with the Indian Society of Hypertension (ISH) and the World Hypertension League (WHL), recently conducted a nationwide blood pressure screening and awareness drive. The campaign, which kicked off on May 17th on occasion of World Hypertension Day, spanned an entire month, engaging over 2,000 healthcare professionals […]

Continue Reading